Loading...
Loading...
CDC PLACES (2023, crude) estimates 16.1% of adults in Paterson have diagnosed diabetes — 4.1 points above the U.S. 12% figure. Census population 159,732. New Jersey Medicare wound biologics: Novitas Solutions (JL). Hawk Medical is a national HCT/P 361 and wound-care distributor serving licensed Paterson clinics — not a walk-in office.
Written for licensed providers. Reviewed by Joe Bradley, Founder & CEO. Content version 2026-09-18. Hawk Medical ships nationwide — this is not a Paterson storefront.
Biologic Solutions for Chronic Wounds in Paterson, NJ for clinics & physicians. Biologic solutions for chr… Compliance support & pricing — contact Hawk Medical.
CDC PLACES (2023, crude) estimates 16.1% of adults in Paterson have diagnosed diabetes — 4.1 points above the U.S. 12% figure. Census city-proper population is 159,732. If you are adding biologic solutions chronic wounds, start with that epidemiology and with Novitas Solutions (JL) — not with a “near me” clinic listing. Hawk Medical ships nationwide; Joe Bradley’s own practice uses the same product classes.
National Biologic Solutions for Chronic Wounds notes (how the product actually works)JL reviewers still want serial wound measurements and conservative-care history before CTPs, whether diabetes in Paterson is 16.1% or not. PLACES is planning data. The LCD is the claim.
We are not going to invent a Paterson warehouse or a five-star local review. What you get is biologic solutions chronic wounds from FDA-registered sources, lot paperwork, and someone who has run the same SOPs in clinic — Joe Bradley. The local numbers on this page are CDC PLACES and CMS JL, not marketing adjectives.
CDC PLACES (2023, crude prevalence) estimates 16.1% of adults — 4.1 points above the U.S. 12% figure. Obesity is 37.5%; arthritis is 20%. That is place-level BRFSS modeling, not a clinic census and not a Paterson trial.
No. They are B2B distribution pages for licensed providers. Patients in Paterson should speak with their clinician, not use a distributor URL as care instructions.
This URL is written for healthcare providers shopping distribution. Patient-facing ads must follow your state medical board and FTC rules. Do not copy distributor language into consumer ads that imply guaranteed healing.
No. Hawk Medical does not distribute products as “stem cell therapy.” HCT/P 361 allografts are regulated under 21 CFR 1271 for homologous use and minimal manipulation. PRP is autologous. Marketing that blurs those lanes is a compliance problem in every state, including New Jersey.
If you operate in New Jersey and another MAC state, say it on the first call. JL will not port 1:1. We would rather split utilization than watch a sister clinic copy Paterson tickets into the wrong jurisdiction.
Contact us to learn how Hawk Medical supports practices in Paterson, NJ.
Hawk Medical is a national distributor. Joe Bradley’s clinic uses the same product classes. What is local for Paterson is JL geography and published epidemiology — not a street address.
CDC PLACES 2023 crude rate for Paterson — 4.1 points above the U.S. 12% figure. Planning input, not an outcomes claim.
New Jersey Part B wound biologics follow this contractor (siblings: DC, DE, MD, PA). We train to the articles. We do not write coverage.
PLACES crude adult arthritis in Paterson. Useful for joint-program math; still needs a diagnosis and privileging.
No Paterson storefront. Joe Bradley is an active practice owner. biologic solutions chronic wounds stays in its regulatory lane — not “FDA-approved stem cell therapy.”
Experience the difference of working with a distributor who understands your practice because we operate one ourselves.